Cathie's Ark Logo
undefined Logo

ARKK Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing
Morning Brew Icon
China's One Ocean Problem
Date
Direction
Shares
Fund Weight
Fund
June 6, 2024
BUY111.403k0.0399%ARKK
June 4, 2024
BUY141.863k0.0536%ARKK
June 3, 2024
BUY76.488k0.0287%ARKK
May 30, 2024
BUY147.582k0.0521%ARKK
May 21, 2024
BUY13.220k0.005%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
3.06%$2.19b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
11🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
211$62.04
🎫ARK Ownership Percent
8.34%

Other ETFs That Hold NTLA

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.95%
ARKKARK Innovation ETF3.77%
GNOMGlobal X Genomics & Biotechnology ETF3.28%
XBISPDR® S&P Biotech ETF1.12%
IBBiShares Biotechnology ETF0.31%
LABUS&P Biotech Bull 3X Shares ETF0.24%

Research Notes and Commentary for NTLA

No Research Notes Found for NTLA